GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cytori Cell Research Institute Inc (TSE:3750) » Definitions » Total Assets

Cytori Cell Research Institute (TSE:3750) Total Assets : 円13,739 Mil (As of Dec. 2023)


View and export this data going back to 2004. Start your Free Trial

What is Cytori Cell Research Institute Total Assets?

Cytori Cell Research Institute's Total Assets for the quarter that ended in Dec. 2023 was 円13,739 Mil.

Warning Sign:

If a company builds assets at 26.4% a year, faster than its revenue growth rate of 11.3% over the past 5 years, it means that the company may be getting less efficient.

During the past 12 months, Cytori Cell Research Institute's average Total Assets Growth Rate was -2.10% per year. During the past 3 years, the average Total Assets Growth Rate was -3.60% per year. During the past 5 years, the average Total Assets Growth Rate was 26.40% per year. During the past 10 years, the average Total Assets Growth Rate was 24.30% per year.

During the past 13 years, Cytori Cell Research Institute's highest 3-Year average Total Assets Growth Rate was 203.90%. The lowest was -47.00%. And the median was 6.80%.

Total Assets is connected with ROA %. Cytori Cell Research Institute's annualized ROA % for the quarter that ended in Dec. 2023 was -3.20%. Total Assets is also linked to Revenue through Asset Turnover. Cytori Cell Research Institute's Asset Turnover for the quarter that ended in Dec. 2023 was 0.04.


Cytori Cell Research Institute Total Assets Historical Data

The historical data trend for Cytori Cell Research Institute's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cytori Cell Research Institute Total Assets Chart

Cytori Cell Research Institute Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7,485.07 15,482.78 14,924.00 16,006.77 14,091.64

Cytori Cell Research Institute Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14,077.56 14,091.64 13,855.20 13,598.41 13,739.11

Cytori Cell Research Institute Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Cytori Cell Research Institute's Total Assets for the fiscal year that ended in Mar. 2023 is calculated as

Total Assets=Total Equity (A: Mar. 2023 )+Total Liabilities (A: Mar. 2023 )
=2656.681+11434.954
=14,092

Cytori Cell Research Institute's Total Assets for the quarter that ended in Dec. 2023 is calculated as

Total Assets=Total Equity (Q: Dec. 2023 )+Total Liabilities (Q: Dec. 2023 )
=2104.536+11634.573
=13,739

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cytori Cell Research Institute  (TSE:3750) Total Assets Explanation

Total Assets is connected with ROA %.

Cytori Cell Research Institute's annualized ROA % for the quarter that ended in Dec. 2023 is

ROA %=Net Income (Q: Dec. 2023 )/( (Total Assets (Q: Sep. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=-437.204/( (13598.409+13739.109)/ 2 )
=-437.204/13668.759
=-3.20 %

Note: The Net Income data used here is four times the quarterly (Dec. 2023) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Cytori Cell Research Institute's Asset Turnover for the quarter that ended in Dec. 2023 is

Asset Turnover
=Revenue (Q: Dec. 2023 )/( (Total Assets (Q: Sep. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=549.058/( (13598.409+13739.109)/ 2 )
=549.058/13668.759
=0.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Cytori Cell Research Institute Total Assets Related Terms

Thank you for viewing the detailed overview of Cytori Cell Research Institute's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Cytori Cell Research Institute (TSE:3750) Business Description

Traded in Other Exchanges
N/A
Address
1-1-1 Otemachi, Otemachi Park Building, Chiyoda-ku, Tokyo, JPN, 100-0004
Cytori Cell Research Institute Inc developing a new clinical approach to cell therapy to provide better medical care to patients by providing medical care that responds to unmet medical needs based on innovative regenerative medicine. Its product pipeline includes Habeo; ECCO-50 and others.

Cytori Cell Research Institute (TSE:3750) Headlines

No Headlines